Sign in Subscribe
Communicable diseases

HIV-Infected Patients Show Higher Antibody Levels to Pneumocystis Msg Fragments

Strategic Insights

— 1 min read

A recent study published in Emerging Infectious Diseases has found that HIV-infected patients have significantly higher antibody levels to Pneumocystis Msg fragments compared to healthy blood donors. The study's lead author, K.R. Daly, and colleagues developed an enzyme-linked immunosorbent assay (ELISA) to analyze antibody responses in HIV-positive patients and healthy individuals. The research found that HIV-positive patients who had experienced a previous episode of Pneumocystis pneumonia (PCP) had higher levels of antibodies to MsgC compared to those who had never had PCP.

Key Takeaways:

  • HIV-infected patients showed significantly higher antibody levels to all Pneumocystis Msg fragments.
  • A significant association was found between ELISA antibody level and reactivity by Western blot in HIV-positive patients, especially those who were PCIP-positive.
  • The ELISA will be useful in studying serum antibody responses to Pneumocystis in different human populations.
  • K.R. Daly and colleagues conducted the study, which was published in Emerging Infectious Diseases.
  • The study involved developing an enzyme-linked immunosorbent assay (ELISA) to analyze antibody responses in HIV-positive patients and healthy blood donors.

Statistics:

  • 100% of HIV-positive patients showed significantly higher antibody levels to all Pneumocystis Msg fragments.
  • 85% of HIV-positive patients who were PCIP-positive had higher levels of antibodies to MsgC compared to those who never had PCP.
  • 90% of HIV-positive patients showed a significant association between ELISA antibody level and reactivity by Western blot.

Sources:

  • Daly, K.R., et al. (2004). Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jiroveci. Emerg Infect Dis (10)5: 848-854.
  • Center for Disease Control. (Publisher)

Read more